Moderna (MRNA) CEO Stéphane Bancel will join a panel in front of the Senate Health, Education, Labor and Pensions Committee (HELP) Wednesday to discuss the company's decision to raise its COVID ...
Stéphane Bancel, chief executive of Moderna, had a good year in 2022, exercising stock options that netted him nearly $393 million. The company decided his pay wasn’t good enough. The Cambridge ...
Big pharma has money to make and the covid vaccine is fertile ground for revenue. But at least one U.S. politician is urging caution. Moderna stock rose this week after CEO Stephane Bancel told ...
The company saw a drop in interest in Covid-19 vaccines and barely beat its 2023 vaccine sales outlook. Now, Moderna is preparing for a push into new markets starting in 2024.
Pfizer Inc. and Moderna Inc. have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported on Sunday. The new price for the Pfizer ...
Moderna said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a ...
Five years from now, Moderna could be synonymous with personalised cancer vaccines, not Covid-19. Chief executive Stéphane Bancel talks with Scottish Mortgage manager Tom Slater about what can ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...
Covid vaccines from companies like Pfizer, Moderna and AstraZeneca were linked to rare occurrences of heart, brain and blood ...
, opens new tab said on Thursday it had paused its plans to build a vaccine manufacturing facility in Kenya, following a post-pandemic decline in demand for COVID-19 vaccines. The move is in line ...
LONDON: Pfizer Inc and Moderna Inc have raised the prices of their COVID-19 vaccines in their latest European Union supply contracts, the Financial Times reported ...